NASDAQ, ICLR - Icon Plc
We are a contract research organization (?CRO?), providing outsourced
development services on a global basis to the pharmaceutical, biotechnology and
medical device industries. We specialize in the strategic development,
management and analysis of programs that support Clinical Development - from
compound selection to Phase I-IV clinical studies.
In a highly fragmented industry, we are one of a small number of companies with
the capability and expertise to conduct clinical trials in all major therapeutic
areas on a global basis. At December 31, 2007, we had 5,610 employees, in 67
locations in 36 countries, providing Phase I - IV Clinical Trial Management,
Drug Development Support Services, Data Management and Biostatistics and Central
Laboratory and Imaging Services. We have the operational flexibility to provide
development services on a stand-alone basis or as part of an integrated ?full
service? solution. ...
Read SEC Filing on NASDAQ.com »